Arca
Skip to content
Tools
Tools

Cell membrane

Subcellular in Bacteria that 13 drugs act on.

  • Drugs that act on it: 13
  • Approved: 5
  • In phases 1 to 3: 8
  • Sponsors: 9

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 6
  • Protein or peptide 4
  • Other 3

Approved5

  • Chlorhexidine
  • Polihexanide
  • Daptomycin
  • Colistimethate
  • Gramicidin

Phase 34

  • Omiganan
  • Pexiganan
  • Pexiganan acetate
  • Surotomycin

Phase 24

  • Benzalkonium
  • C16G2
  • LTX-109
  • Olanexidine

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    • Cutempa Medical AG215%
    • Armata Pharmaceuticals, Inc.18%
    • Dipexium Pharmaceuticals, Inc.18%
    • Pharma Holdings AS18%
    • Valenta Pharm JSC18%

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 9 of 13 act as: Cell membrane disrupting agent; the rest name their own mechanism.
    ChlorhexidineWithdrawnApprovedCutempa Medical AGSmall moleculeInhibitorCell membrane inhibitor208
    PolihexanideApprovedCutempa Medical AGSmall moleculeDisrupting agent13
    DaptomycinApprovedMerck & Co. (MSD)Small moleculeInhibitorCell membrane inhibitor11
    ColistimethateApprovedPH HealthOtherInhibitorCell membrane inhibitor10
    GramicidinApprovedValenta Pharm JSCOtherInhibitorCell membrane inhibitor3
    OmigananPhase 3Maruho MedicalProtein or peptideDisrupting agent0
    PexigananPhase 3Dipexium Pharmaceuticals, Inc.Protein or peptideDisrupting agent0
    Pexiganan acetatePhase 3Abeona TherapeuticsProtein or peptideDisrupting agent0
    SurotomycinPhase 3Merck & Co. (MSD)Protein or peptideDisrupting agent0
    BenzalkoniumBoxed warningPhase 2—Small moleculeDisrupting agent8
    C16G2Phase 2Armata Pharmaceuticals, Inc.OtherDisrupting agent0
    LTX-109Phase 2Pharma Holdings ASSmall moleculeDisrupting agent0
    OlanexidinePhase 2—Small moleculeDisrupting agent0

    Open trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 42 in all, from ClinicalTrials.gov.
    Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsChlorhexidine, PolihexanideNot applicableRecruitingCutempa Medical AGNov 13, 2026
    Ultrasound-Guided Percutaneous Electrolysis Plus Exercise for Chronic Supraspinatus TendinopathyChlorhexidineNot applicableEnrolling by invitationDAVID CRUZ DÍAZNov 10, 2026
    Ozone Gel Versus Chlorohexidine Gel as an Adjunct to Non-Surgical Treatment of Stage II Periodontitis Grade B Among Smokers PatientsChlorhexidineNot applicableRecruitingOctober 6 UniversityNov 6, 2026
    Soap-and-Water Bed Bath Versus Disposable Wipe Bath in the Same ICU PatientsChlorhexidine—Not yet recruitingSinop Atatürk State HospitalNov 5, 2026
    A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After MastectomyChlorhexidinePhase 2RecruitingMemorial Sloan Kettering Cancer CenterNov 5, 2026
    Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot StudyChlorhexidineNot applicableNot yet recruitingUniversity of Medicine and Pharmacy at Ho Chi Minh CityNov 5, 2026
    Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast CancerBenzalkoniumPhase 2Not yet recruitingWashington University School of MedicineNov 3, 2026
    Targeted Antimicrobial Comparison for Treatment Individualization in Critically Ill Patients With CRAB InfectionColistimethate—Not yet recruitingCentral South UniversityOct 29, 2026
    Oral Mucosal Grafting for Nasal Septal Perforation RepairChlorhexidine—Not yet recruitingInstituto de Investigación Sanitaria de la Fundación Jiménez DíazOct 29, 2026
    Efficacy of Thymus Vulgaris Mouthwash in the Management of Biofilm-Induced GingivitisChlorhexidinePhase 2Not yet recruitingUniversity of SulaimaniOct 29, 2026
    Brain Dopamine BiomarkerBenzalkonium—Not yet recruitingUniversity of South FloridaAug 6, 2026
    Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.ColistimethatePhase 4Active, not recruitingBeni-Suef UniversityJul 10, 2026
    Investigation of the PREVENTIA® Irrigation Solution for Reducing Bacteria in Spinal Surgery With Implants - A Comparative StudyPolihexanidePhase 4Not yet recruitingUniversität LuzernJun 24, 2026
    Subcutaneous Suture Versus no Subcutaneous Suture for Abdominal Wound ClosurePolihexanideNot applicableRecruitingUniversity Hospital AugsburgMay 29, 2026
    Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hyaluronate Carbomer Composite HydrogelBenzalkoniumNot applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical CollegeMay 6, 2026
    Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaColistimethatePhase 2RecruitingChia Tai Tianqing Pharmaceutical Group Co., Ltd.Apr 6, 2026
    Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure UlcersPolihexanideEarly phase 1Not yet recruitingFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaFeb 6, 2026
    Combination Antibiotic Therapy for Staphylococcus Aureus BacteremiaDaptomycinPhase 4RecruitingIntermountain Health Care, Inc.Jan 29, 2026
    Impact of Prontosan Wound Gel X on Surgical Site Infections in Cardiac SurgeryPolihexanide—RecruitingIRCCS Policlinico S. DonatoDec 10, 2025
    In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care UnitDaptomycin—RecruitingNiguarda HospitalNov 17, 2025
    Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?DaptomycinPhase 4Enrolling by invitationWest Virginia UniversityAug 29, 2025
    Hybrid Osteoplasty Versus Osteotomy in RhinoplastyBenzalkoniumNot applicableActive, not recruitingUniversity of SulaimaniAug 26, 2025
    Antibiotic Impregnated Beads in OsteomyelitisDaptomycinPhase 4Not yet recruitingUniversity of ArizonaJul 18, 2025
    Impact of Three Probabilistic Antibiotic Therapy on Digestive Microbiota and Colonization With Multi-resistant BacteriaDaptomycinNot applicableNot yet recruitingCentre Hospitalier Universitaire de NiceJul 10, 2025
    Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.BenzalkoniumPhase 4RecruitingTelethon Kids InstituteJun 3, 2025
    Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review StudyDaptomycin—Active, not recruitingNational Taiwan University HospitalMay 6, 2025
    Participant Satisfaction and Quality of Life With Catheter Washouts in Adults Living With Long-Term Catheters and Currently Using Uro-Tainer® Polihexanide 0.02%Polihexanide—Not yet recruitingB. Braun Ltd. Centre of Excellence Infection ControlApr 10, 2025
    Comparative Study of Clinical Outcomes and Safety Between Colistin and TigecyclineColistimethatePhase 4Active, not recruitingBeni-Suef UniversityMar 25, 2025
    Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy VolunteersGramicidinPhase 1RecruitingValenta Pharm JSCMar 5, 2025
    Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy VolunteersGramicidinPhase 1RecruitingValenta Pharm JSCMar 5, 2025
    Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, LozengesGramicidinPhase 2RecruitingValenta Pharm JSCFeb 24, 2025
    Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled TrialColistimethateNot applicableRecruitingQilu Hospital of Shandong UniversityFeb 19, 2025
    Comparing Tigecycline Vs. Colistimethate in CNS InfectionsColistimethate—Not yet recruitingAin Shams UniversityNov 25, 2024
    Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus BacteraemiaDaptomycin—Active, not recruitingHospital Universitari de BellvitgeNov 19, 2024
    Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus BacteremiaDaptomycinPhase 4RecruitingTodd C. Lee MD MPH FIDSAOct 15, 2024
    A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot UlcersPolihexanideNot applicableRecruitingOrganogenesisOct 1, 2024
    Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated PneumoniaColistimethatePhase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma BourguibaJul 5, 2024
    Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With BronchiectasisColistimethatePhase 2RecruitingCentre Hospitalier Intercommunal CreteilApr 16, 2024
    Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring ClosurePolihexanidePhase 4RecruitingUniversity of Nevada, Las VegasMar 13, 2024
    Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)BenzalkoniumPhase 2RecruitingCedars-Sinai Medical CenterMar 11, 2022
    Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet CellsBenzalkoniumPhase 4RecruitingCopenhagen University Hospital, RigshospitaletJul 12, 2021
    Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United KingdomBenzalkoniumPhase 2Active, not recruitingBelfast Health and Social Care TrustOct 1, 2018

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364031, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.